Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.
In June 2005, an ad hoc Expert Committee formed by the Pituitary Society convened during the 9th International Pituitary Congress in San Diego, California. Members of this committee consisted of invited international experts in the field, and included endocrinologists and neurosurgeons with recognized expertise in the management of prolactinomas. Discussions were held that included all interested participants to the Congress and resulted in formulation of these guidelines, which represent the current recommendations on the diagnosis and management of prolactinomas based upon comprehensive analysis and synthesis of all available data.
Casanueva
Felipe F
FF
Department of Medicine, Endocrine Division, Santiago de Compostela University, Spain. endocrine@usc.es
Molitch
Mark E
ME
Schlechte
Janet A
JA
Abs
Roger
R
Bonert
Vivien
V
Bronstein
Marcello D
MD
Brue
Thierry
T
Cappabianca
Paolo
P
Colao
Annamaria
A
Fahlbusch
Rudolf
R
Fideleff
Hugo
H
Hadani
Moshe
M
Kelly
Paul
P
Kleinberg
David
D
Laws
Edward
E
Marek
Josef
J
Scanlon
Maurice
M
Sobrinho
Luis G
LG
Wass
John A H
JA
Giustina
Andrea
A
D000236:Adenoma / Q000175:diagnosis / Q000628:therapy; D000328:Adult; D000465:Algorithms; D002648:Child; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006966:Hyperprolactinemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D008297:Male; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis / Q000628:therapy; D015175:Prolactinoma / Q000175:diagnosis / Q000628:therapy
D018491:Dopamine Agonists